High expression of vascular endothelial growth factor A (VEGF-A), which is a key contributor in the formation of new blood vessels from preexisting vasculature, was observed in more than half of stomach cancers, and it is intimately relevant to clinicopathological features, including TNM stage, tumor size, positive lymph nodes, and lymphovascular invasion [21]. This evidence concerns the gene VEGFA and gastric cancer.